Luisa Vonghia
University of Antwerp · 171 works · 6,628 citations · h-index 34
Top works
- Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study
- Assessment of biopsy‐proven liver fibrosis by two‐dimensional shear wave elastography: An individual patient data‐based meta‐analysis
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- Acute alcohol intoxication
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
- Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
- Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
- State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting
- Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
- Shear‐wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study
- Primary renal angiosarcoma: A rare malignancy. A case report and review of the literature☆
- Screening for therapeutic trials and treatment indication in clinical practice: MACK ‐3, a new blood test for the diagnosis of fibrotic NASH
- An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
- Relationship Between Ghrelin Levels, Alcohol Craving, and Nutritional Status in Current Alcoholic Patients
- The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
- Microbiome-derived ethanol in nonalcoholic fatty liver disease
- Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution
- Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin
- Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction
- Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects